Cargando…

Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension

BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Rain, Silvia, Bos, Denielli da Silva Goncalves, Handoko, M. Louis, Westerhof, Nico, Stienen, Ger, Ottenheijm, Coen, Goebel, Max, Dorfmüller, Peter, Guignabert, Christophe, Humbert, Marc, Bogaard, Harm‐Jan, dos Remedios, Cris, Saripalli, Chandra, Hidalgo, Carlos G., Granzier, Henk L., Vonk‐Noordegraaf, Anton, van der Velden, Jolanda, de Man, Frances S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309054/
https://www.ncbi.nlm.nih.gov/pubmed/24895160
http://dx.doi.org/10.1161/JAHA.113.000716
_version_ 1782354627060039680
author Rain, Silvia
Bos, Denielli da Silva Goncalves
Handoko, M. Louis
Westerhof, Nico
Stienen, Ger
Ottenheijm, Coen
Goebel, Max
Dorfmüller, Peter
Guignabert, Christophe
Humbert, Marc
Bogaard, Harm‐Jan
dos Remedios, Cris
Saripalli, Chandra
Hidalgo, Carlos G.
Granzier, Henk L.
Vonk‐Noordegraaf, Anton
van der Velden, Jolanda
de Man, Frances S.
author_facet Rain, Silvia
Bos, Denielli da Silva Goncalves
Handoko, M. Louis
Westerhof, Nico
Stienen, Ger
Ottenheijm, Coen
Goebel, Max
Dorfmüller, Peter
Guignabert, Christophe
Humbert, Marc
Bogaard, Harm‐Jan
dos Remedios, Cris
Saripalli, Chandra
Hidalgo, Carlos G.
Granzier, Henk L.
Vonk‐Noordegraaf, Anton
van der Velden, Jolanda
de Man, Frances S.
author_sort Rain, Silvia
collection PubMed
description BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifications contributing to cellular diastolic dysfunction in PAH. METHODS AND RESULTS: RV samples from PAH patients undergoing heart‐lung transplantation were compared to non‐failing donors (Don). Titin stiffness contribution to RV diastolic dysfunction was determined by Western‐blot analyses using antibodies to protein‐kinase‐A (PKA), Cα (PKCα) and Ca(2+)/calmoduling‐dependent‐kinase (CamKIIδ) titin and phospholamban (PLN) phosphorylation sites: N2B (Ser469), PEVK (Ser170 and Ser26), and PLN (Thr17), respectively. PKA and PKCα sites were significantly less phosphorylated in PAH compared with donors (P<0.0001). To test the functional relevance of PKA‐, PKCα‐, and CamK(IIδ)‐mediated titin phosphorylation, we measured the stiffness of single RV cardiomyocytes before and after kinase incubation. PKA significantly decreased PAH RV cardiomyocyte diastolic stiffness, PKCα further increased stiffness while CamK(IIδ) had no major effect. CamKIIδ activation was determined indirectly by measuring PLN Thr17phosphorylation level. No significant changes were found between the groups. Myofilament Ca(2+) sensitivity is mediated by sarcomeric troponin I (cTnI) phosphorylation. We observed increased unphosphorylated cTnI in PAH compared with donors (P<0.05) and reduced PKA‐mediated cTnI phosphorylation (Ser22/23) (P<0.001). Finally, alterations in Ca(2+)‐handling proteins contribute to RV diastolic dysfunction due to insufficient diastolic Ca(2+) clearance. PAH SERCA2a levels and PLN phosphorylation were significantly reduced compared with donors (P<0.05). CONCLUSIONS: Increased titin stiffness, reduced cTnI phosphorylation, and altered levels of phosphorylation of Ca(2+) handling proteins contribute to RV diastolic dysfunction in PAH.
format Online
Article
Text
id pubmed-4309054
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43090542015-01-28 Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension Rain, Silvia Bos, Denielli da Silva Goncalves Handoko, M. Louis Westerhof, Nico Stienen, Ger Ottenheijm, Coen Goebel, Max Dorfmüller, Peter Guignabert, Christophe Humbert, Marc Bogaard, Harm‐Jan dos Remedios, Cris Saripalli, Chandra Hidalgo, Carlos G. Granzier, Henk L. Vonk‐Noordegraaf, Anton van der Velden, Jolanda de Man, Frances S. J Am Heart Assoc Original Research BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifications contributing to cellular diastolic dysfunction in PAH. METHODS AND RESULTS: RV samples from PAH patients undergoing heart‐lung transplantation were compared to non‐failing donors (Don). Titin stiffness contribution to RV diastolic dysfunction was determined by Western‐blot analyses using antibodies to protein‐kinase‐A (PKA), Cα (PKCα) and Ca(2+)/calmoduling‐dependent‐kinase (CamKIIδ) titin and phospholamban (PLN) phosphorylation sites: N2B (Ser469), PEVK (Ser170 and Ser26), and PLN (Thr17), respectively. PKA and PKCα sites were significantly less phosphorylated in PAH compared with donors (P<0.0001). To test the functional relevance of PKA‐, PKCα‐, and CamK(IIδ)‐mediated titin phosphorylation, we measured the stiffness of single RV cardiomyocytes before and after kinase incubation. PKA significantly decreased PAH RV cardiomyocyte diastolic stiffness, PKCα further increased stiffness while CamK(IIδ) had no major effect. CamKIIδ activation was determined indirectly by measuring PLN Thr17phosphorylation level. No significant changes were found between the groups. Myofilament Ca(2+) sensitivity is mediated by sarcomeric troponin I (cTnI) phosphorylation. We observed increased unphosphorylated cTnI in PAH compared with donors (P<0.05) and reduced PKA‐mediated cTnI phosphorylation (Ser22/23) (P<0.001). Finally, alterations in Ca(2+)‐handling proteins contribute to RV diastolic dysfunction due to insufficient diastolic Ca(2+) clearance. PAH SERCA2a levels and PLN phosphorylation were significantly reduced compared with donors (P<0.05). CONCLUSIONS: Increased titin stiffness, reduced cTnI phosphorylation, and altered levels of phosphorylation of Ca(2+) handling proteins contribute to RV diastolic dysfunction in PAH. Blackwell Publishing Ltd 2014-06-03 /pmc/articles/PMC4309054/ /pubmed/24895160 http://dx.doi.org/10.1161/JAHA.113.000716 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Rain, Silvia
Bos, Denielli da Silva Goncalves
Handoko, M. Louis
Westerhof, Nico
Stienen, Ger
Ottenheijm, Coen
Goebel, Max
Dorfmüller, Peter
Guignabert, Christophe
Humbert, Marc
Bogaard, Harm‐Jan
dos Remedios, Cris
Saripalli, Chandra
Hidalgo, Carlos G.
Granzier, Henk L.
Vonk‐Noordegraaf, Anton
van der Velden, Jolanda
de Man, Frances S.
Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title_full Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title_fullStr Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title_full_unstemmed Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title_short Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
title_sort protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309054/
https://www.ncbi.nlm.nih.gov/pubmed/24895160
http://dx.doi.org/10.1161/JAHA.113.000716
work_keys_str_mv AT rainsilvia proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT bosdeniellidasilvagoncalves proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT handokomlouis proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT westerhofnico proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT stienenger proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT ottenheijmcoen proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT goebelmax proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT dorfmullerpeter proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT guignabertchristophe proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT humbertmarc proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT bogaardharmjan proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT dosremedioscris proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT saripallichandra proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT hidalgocarlosg proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT granzierhenkl proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT vonknoordegraafanton proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT vanderveldenjolanda proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension
AT demanfrancess proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension